APMA Joins Forces with Alira Health to Advance APMA Registry

APMA is pleased to announce that we have joined forces with Alira Health, a global advisory and clinical research firm to help advance the APMA Registry. APMA, along with Alira Health’s deep clinical and Real-World Evidence (RWE) expertise, will bring more insight into real patient experiences, contributing to better outcomes. The real-world evidence in the APMA Registry has tremendous potential to advance clinical research around diabetic foot ulcers with data that is representative of the actual patient journey podiatric physicians see in practice.

“Our partnership with APMA marks an advancement in accelerating innovation and new solutions for patients,” said Gabriele Brambilla, CEO of Alira Health. “It is another important step to help our partners develop new treatments for DFUs and prevent over 150,000 amputations a year in the USA.”

APMA will let you know how you can get involved in these efforts as the program progresses.